XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Operating activities:    
Net income (loss) $ 116,604,000 $ (30,598,000)
Adjustments to reconcile net income (loss) to net cash provided from operating activities:    
Deferred income tax expense 45,787,000 14,158,000
Depletion, depreciation and amortization and impairment 280,223,000 345,906,000
Exploration dry hole costs 0 2,000
Abandonment and impairment of unproved properties 25,429,000 66,695,000
Derivative fair value (income) loss (133,514,000) 117,299,000
Cash settlements on derivative financial instruments 58,341,000 (5,350,000)
Allowance for doubtful accounts 0 (1,500,000)
Amortization of deferred financing costs and other 3,243,000 2,376,000
Deferred and stock-based compensation 13,727,000 34,167,000
Gain on the sale of assets (5,678,000) (179,000)
Changes in working capital:    
Accounts receivable 201,428,000 (14,425,000)
Inventory and other (5,035,000) 796,000
Accounts payable (29,132,000) 14,615,000
Accrued liabilities and other (125,907,000) 1,553,000
Net cash provided from operating activities 445,516,000 545,515,000
Investing activities:    
Additions to natural gas and oil properties (380,718,000) (584,432,000)
Additions to field service assets (697,000) (1,863,000)
Acreage purchases (31,920,000) (37,900,000)
Proceeds from disposal of assets 34,366,000 366,000
Purchases of marketable securities held by the deferred compensation plan (15,170,000) (27,271,000)
Proceeds from the sales of marketable securities held by the deferred compensation plan 18,226,000 25,459,000
Net cash used in investing activities (375,913,000) (625,641,000)
Financing activities:    
Borrowings on credit facilities 1,151,000,000 1,114,000,000
Repayments on credit facilities (1,199,000,000) (1,011,000,000)
Dividends paid (10,049,000) (9,960,000)
Taxes paid for shares withheld (3,343,000) (3,021,000)
Debt issuance costs 0 (8,257,000)
Change in cash overdrafts (8,762,000) (7,318,000)
Proceeds from the sales of common stock held by the deferred compensation plan 513,000 5,649,000
Net cash (used in) provided from financing activities (69,641,000) 80,093,000
Decrease in cash and cash equivalents (38,000) (33,000)
Cash and cash equivalents at beginning of period 545,000 448,000
Cash and cash equivalents at end of period $ 507,000 $ 415,000